Trial Profile
The effectiveness of Vonoprazan for ulcer healing and prevention of delayed bleeding after gastric ESD: a prospective observational study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Nov 2019
Price :
$35
*
At a glance
- Drugs Vonoprazan (Primary)
- Indications Gastric ulcer; Perioperative haemorrhage
- Focus Therapeutic Use
- 26 Nov 2019 Planned number of patients changed from 300 to 250.
- 31 Jan 2019 Status changed from active, no longer recruiting to completed.
- 11 Nov 2018 Status changed from recruiting to active, no longer recruiting.